Seguir
Mark Buyyounouski
Mark Buyyounouski
Email confirmado em stanford.edu - Página inicial
Título
Citado por
Citado por
Ano
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
A Pollack, G Walker, EM Horwitz, R Price, S Feigenberg, AA Konski, ...
Journal of Clinical Oncology 31 (31), 3860, 2013
5022013
Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology
TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the National Comprehensive Cancer Network 18 (3), 329-354, 2020
4992020
RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer
CAF Lawton, J Michalski, I El-Naqa, MK Buyyounouski, WR Lee, ...
International Journal of Radiation Oncology* Biology* Physics 74 (2), 383-387, 2009
4282009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ...
International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010
4082010
Prostate cancer–major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
MK Buyyounouski, PL Choyke, JK McKenney, O Sartor, HM Sandler, ...
CA: a cancer journal for clinicians 67 (3), 245-253, 2017
3992017
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to …
PW Sperduto, M Wang, HI Robins, MC Schell, M Werner-Wasik, R Komaki, ...
International Journal of Radiation Oncology* Biology* Physics 85 (5), 1312-1318, 2013
3232013
Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer
SA Boorjian, RJ Karnes, R Viterbo, LJ Rangel, EJ Bergstralh, EM Horwitz, ...
Cancer 117 (13), 2883-2891, 2011
3232011
An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee
AM Allen, T Pawlicki, L Dong, E Fourkal, M Buyyounouski, K Cengel, ...
Radiotherapy and Oncology 103 (1), 8-11, 2012
2982012
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
A Pollack, AL Hanlon, EM Horwitz, SJ Feigenberg, AA Konski, B Movsas, ...
International Journal of Radiation Oncology* Biology* Physics 64 (2), 518-526, 2006
2912006
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
2562019
Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology
PE Spiess, N Agarwal, R Bangs, SA Boorjian, MK Buyyounouski, ...
Journal of the National Comprehensive Cancer Network 15 (10), 1240-1267, 2017
2472017
NCCN guidelines insights: bladder cancer, version 5.2018
TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the national comprehensive cancer network 16 (9), 1041-1053, 2018
2362018
Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome
MA Rubin, M Buyyounouski, E Bagiella, S Sharir, A Neugut, M Benson, ...
Urology 53 (3), 542-547, 1999
2011999
What dose of external-beam radiation is high enough for prostate cancer?
TN Eade, AL Hanlon, EM Horwitz, MK Buyyounouski, GE Hanks, ...
International Journal of Radiation Oncology* Biology* Physics 68 (3), 682-689, 2007
1952007
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
MC Abramowitz, T Li, MK Buyyounouski, E Ross, RG Uzzo, A Pollack, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
1942008
Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline
SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...
Practical radiation oncology 8 (6), 354-360, 2018
1902018
Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline
SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...
Journal of Clinical Oncology 36 (34), 3411, 2018
1712018
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients …
T Mitin, D Hunt, WU Shipley, DS Kaufman, R Uzzo, CL Wu, ...
The lancet oncology 14 (9), 863-872, 2013
1562013
NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines
TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022
1262022
Prostate cancer classification with multiparametric MRI transfer learning model
Y Yuan, W Qin, M Buyyounouski, B Ibragimov, S Hancock, B Han, L Xing
Medical physics 46 (2), 756-765, 2019
1192019
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20